Clarity Pharmaceuticals

About:

Clarity Pharmaceuticals is a personalized medicine company focused on the treatment of serious disease.

Website: http://www.claritypharmaceuticals.com/

Top Investors: Cicada Innovations, University of Melbourne, Sydney Angels, Australian Nuclear Science and Technology Organization, ATP Innovations

Description:

Clarity is a personalized medicine company focused on the treatment of serious disease. The Company is a leader in innovative radiopharmaceutical technology, developing targeted therapies and assisting in the drug development pipeline of novel therapies for companies globally. Clarity’s platform technology allows antibodies to be radiolabeled and visualized using PET imaging. The human imaging data generated provides information on whether the drug reaches the desired disease target in a patient. This information enables a personalized approach to therapy by only treating those patients that are likely to respond to therapy and excluding those that won’t respond to therapy. This precision medicine approach is at the forefront of drug development.

Total Funding Amount:

$9.67M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Sydney, New South Wales, Australia

Founded Date:

2010-01-01

Contact Email:

sales(AT)claritypharmaceuticals.com

Founders:

Matt Harris

Number of Employees:

11-50

Last Funding Date:

2017-06-29

IPO Status:

Public

Industries:

© 2025 bioDAO.ai